Skip to main content

Table 3 Patients’ intraoperative and postoperative parameters

From: Comparison of different methods of splenic hilar lymph node dissection for advanced upper- and/or middle-third gastric cancer

 

In situ (n = 68)

Ex situ (n = 118)

Splenectomy (n = 31)

Pvalue

No. of harvested SHLNs, median (range)

1(1–4)

2(1–7)

2(1–7)

0.047

No. of total harvested LNs, median (range)

33(10–66)

33(11–78)

31(11–60)

0.313

Postoperative hospital stay, days, (mean ± standard deviation)

16.41 ± 3.06

15.11 ± 1.53

23.26 ± 4.74

0.001

Blood loss volume, ml, (mean ± standard deviation)

211.62 ± 53.43

180.08 ± 24.71

262.90 ± 78.09

0.027

Operation duration, min, (mean ± standard deviation)

242.66 ± 18.90

244.24 ± 13.66

247.65 ± 22.06

0.695

Postoperative complication rate, n (%)

12(17.6 %)

15(12.7 %)

11(35.5 %)

0.011

Bleeding, n (%)

1 (1.5 %)

3 (2.5 %)

3 (9.7 %)

0.153

Anastomotic leak, n (%)

3 (4.4 %)

6 (5.1 %)

5 (16.1 %)

0.111

Pancreatic fistula, n (%)

0 (0.0 %)

0 (0.0 %)

2 (6.5 %)

0.019

Abdominal effusion, n (%)

6 (8.8 %)

7 (5.9 %)

5 (16.1 %)

0.183

Abdominal infection, n (%)

6 (8.8 %)

8 (6.8 %)

7(22.6 %)

0.029

Pneumonia, n (%)

3 (8.8 %)

1 (0.8 %)

1(3.2 %)

0.269

Reoperation rate, n (%)

3(4.4 %)

3(2.5 %)

2(6.5 %)

0.359

Mortality rate, n (%)

0(0 %)

1(0.8 %)

1(3.2 %)

0.363

  1. SHLNs splenic hilar lymph nodes, LNs lymph nodes